
Description
Our client, a global biopharmaceutical company that finds and delivers novel treatments for patients with a significant unmet need, has an immediate opening for a Senior Scientist.
Responsibilities:
- Serve as a formulation subject matter expert to cross-functional Technical Operations, CMC, and program teams
- Design and carry out formulation development and drug product development studies
- Analyze, trend, and interpret formulation development, stability, and production data
- Support technical oversight of drug product CDMOs and GMP manufacturing operations
- Review and approve GMP manufacturing and quality documents as a technical expert such as batch records and production data
- Develop, author, review, and approve protocols, reports, and process descriptions
- Contribute to regulatory filing submissions (such as IND, BLA, MAA)
- Stay current with the regulatory requirements, industry trends, and new emerging technologies as it relates to formulation development and drug product development
- Other duties as required
Requirements:
- BS/MS/Ph.D. in chemistry, biochemistry, (bio)chemical engineering pharmaceutical sciences (or other relevant physical or life sciences discipline). Graduate degree preferred
- 3-5+ years of biologics formulation development experience in pharma/biotech
- Experience with drug product development and in-use studies a plus
- Proven ability to apply the principles of the basic sciences, such as physical and organic chemistry, thermodynamics, and materials science, to pre-formulation and formulation development, using a rational, scientific approach
- Hands on knowledge of common protein analytical techniques such as HPLC, DSC, iCIEF, CE-SDS, subvisible particle characterization, and biophysical methods
- Maintain a high level of productivity in the lab requiring only minimal direction
- Effectively and concisely communicate scientific rationale and data to project teams
- Strong technical writing and data analysis skills
- Experience in collaborating with external labs and CDMOs a plus